ProMetic Life Sciences, Inc.
ProMetic Life Sciences Inc. is a global biopharmaceutical company. The company is specialized in the design of small molecules that mimic unique and specific interactions between proteins, research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary mimetic ligand technology. This technology is used in large-scale purification of biologics, drug development, proteomics and the elimination of pathogens. It operates through two segments: Small Molecule Therapeutics and Protein Technology. ProMetic Life Sciences also develops novel therapeutic products targeting medical needs in the field of fibrosis, anemia, neutropenia, cancer and autoimmune diseases/inflammation as well as certain nephropathies. The company was founded by Pierre Laurin on October 14, 1994 and is headquartered in Laval, Canada.